Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH publishes report on One Health opportunities
The report explores how the veterinary industry can support One Health and the UK's sustainability.

The new report recommends future steps for sustainability.

The National Office of Animal Health (NOAH) has published a new report, detailing how the animal health industry can support global One Health and sustainability.

Within the report, the trade association has produced recommendations of how organisations across the industry can contribute to the cause.

Among the recommendations in the report is a regulatory framework for veterinary medicines, which NOAH says would ensure safe medicines stay available and accessible for all animals. The association says that updated UK Veterinary Medicines Regulations would remove unnecessary burdens, and include novel and innovative products.

Furthermore, they have stated the importance that routes for veterinary medicines to market remain available. This would mean that animal owners can continue to access veterinary medicines, with necessary prescription controls.

NOAH has also pushed for better collaboration and partnership between human, animal and environmental sectors in finding sustainable One Health solutions to challenges that affect any sector.

Other recommendations made in NOAH’s report include training for farmers on disease prevention, increased awareness on responsible medicine use, assured funding for development of new medicines and improved diagnostics of diseases in animals.

The guidance has been created with a One Health approach, which suggests that animal, human and environmental health are interconnected and should be considered as a whole. NOAH believes that, by following their recommendations, the veterinary industry will contribute significantly to 10 out of 17 of the Sustainable Development Goals set by the United Nations in its 2030 agenda.

The organisation says that these steps will support the UK with reaching economic viability, holding environmental responsibility and protecting the health of society.

Dawn Howard, NOAH chief executive, said: “The animal health industry is dedicated to a One Health approach to identify and interpret problems, and to find and apply One Health solutions for a healthy balance across all three systems. Achieving this healthy balance is a key element in achieving a sustainable present and future for human and animal health and the health of the planet we share.

“We’re proud to put together this report which outlines examples of where the work of the animal health sector contributes to One Health, and the UK’s sustainability goals.”

The full report can be found here.

Image © NOAH

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.